Pharmacological effect of walnuts consumption on metabolic syndrome: a current view

Authors

  • Casimir C. Ofor epartment of Pharmacology, Ebonyi State University, Abakaliki, Nigeria
  • Eugene O. Ohanme Department of Pharmacology, Alex Ekwueme Federal University, Abakaliki, Nigeria
  • Benjamin N. Nwakelu Department of Pharmacology, Alex Ekwueme Federal University, Abakaliki, Nigeria
  • Uzochukwu Ofornakara Department of Pharmacology, Alex Ekwueme Federal University, Abakaliki, Nigeria
  • Daniel O. Aja Department of Pharmacology, Ebonyi State University, Abakaliki, Nigeria
  • Elvis N. Shu Department of Pharmacology, University of Nigeria, Nsukka, Nigeria
  • Samuel I. Ghasi Department of Pharmacology, University of Nigeria, Nsukka, Nigeria

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20241656

Keywords:

Metabolic syndrome, CVD, Walnuts, Oxidative stress

Abstract

Cardiovascular disease (CVD) is the leading cause of death worldwide (WHO, 2017). In addition to the global and national morbidity and mortality burdens of the disease, it imposes a substantial economic burden on society. The American heart association predicts that by 2035, 45% of Americans will suffer from CVD with costs expected to reach $1.1 trillion annually. Clinical trials have demonstrated that a nut-containing diet low in saturated fat and cholesterol, while high in poly and monounsaturated fatty acids has a beneficial effect on plasma lipids and lipoproteins when compared with either a low fat or average American diet. Other bioactive compounds present in walnuts, including micronutrients, fiber, and phytochemicals, may also contribute to their cardio protective effect by reducing inflammation, improving vascular reactivity, and lowering oxidative stress. It has been demonstrated that the consumption of walnuts resulted in significant reduction in body mass index (BMI), percentage of body fat, increased lean body mass and an increased amount of water in the body. A large population cohort study also demonstrated a marked reduction in body weight and other anthropometric parameters in people on regular consumption of walnuts.

References

American Heart Association Symptoms and Diagnosis of Metabolic Syndrome. Available at: http://www.heart.org/HEARTORG/Conditions/More/MetabolicSyndrome/Symptoms-and-Diagnosis-of-Metabolic-Syndrome_UCM_301925_Article.jsp. Accessed on 15 March, 2024.

National Heart Lung and Blood Institute What is Metabolic Syndrome? Available at: https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome#. Accessed on 15 March, 2024.

Abdrabalnabi A, Rajaram S, Bitok E, Oda K, Beeson WL, Kaur A, et al. Effects of Supplementing the Usual Diet with a Daily Dose of Walnuts for Two Years on Metabolic Syndrome and Its Components in an Elderly Cohort. Nutrients. 2020;12(2):451.

Bošković M, Živković M, Koricanac G, Snezana T, Manja Z, Jasmina D-M, et al. Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart. Front Physiol. 2022;13:942459.

World Health Organization. Healthy diet. Available at: https://www.who.int/news-room/fact-sheets/detail/healthy-diet. Accessed on 18 March, 2024.

Bamberger C, Rossmeier A, Lechner K. A walnut-enriched diet reduces lipids in healthy Caucasian subjects, independent of recommended macronutrient replacement and time point of consumption: a prospective, randomized, controlled trial. Nutrients. 2017;9:1097.

Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629-36.

Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis. 2017;14:E24.

Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013;62(8):697-703.

Ros E, Izquierdo-Pulido M, Sala-Vila A. Beneficial effects of walnut consumption on human health: Role of micronutrients. Curr Opin Clin Nutr Metab Care. 2018;21(6):498-504.

King JC, Blumberg J, Ingwersen L, Jenab M, Tucker KL. Tree nuts and peanuts as components of a healthy diet. J Nutr. 2008;138:1736S-40S.

Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: A review of clinical studies. Br J Nutr. 2006;96(2):S68-78.

Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138:S1746-51.

Sala-Vila A, Fleming J, Kris-Etherton P, Ros E. Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition. Adv. Nutr. 2022;13:1584-602.

Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: A randomized controlled, crossover trial. J Am Call Nutr. 2012;31:415-23.

Li J, Jiang B, Santos HO, Santos D, Singh A, Wang L. Effects of walnut intake on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2020;34(11):2921-31.

Berryman CE, Grieger JA, West SG, Chen CY, Blumberg JB, Rothblat GH, Sankaranarayanan S, Kris-Etherton PM. Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia. J Nutr. 2013;143(6):788-94.

Abbaspour N, Roberts T, Hooshmand S, Kern M, Hong MY. Mixed Nut Consumption May Improve Cardiovascular Disease Risk Factors in Overweight and Obese Adults. Nutrients. 2019;11(7):1488.

Casas-Agustench P, Bullo M, Ros E, Basora J, Salas-Salvado J. Cross-sectional association of nut intake with adiposity in a Mediterranean population. tr. Metab Cardiovasc Dis. 2011;21(7):518-25.

Lee YJ, Nam GE, Seo JA, Yoon X, Seo I, Lee JH, et al. Nut consumption has favorable effects on lipid profiles of Korean women with metabolic syndrome. Nutr Res. 2014;34(9):814-20.

Hosseini A, Razavi BM, Hosseinzadeh H. Pharmacokinetic Properties of Saffron and its Active Components. Eur J Drug Metab Pharmacokinet. 2018;43(4):383-90.

Ashraf S, Arfeen A, Amjad S, Ahmed Z. Effect of walnut (Juglans regia) consumption on hyperlipidemic adults. Cienc Technol Aliment. 2021;41:432-8.

Parham M, Bagherzadeh M, Asghari M, Akbari H, Hosseini Z, Rafiee M, et al. Evaluating the effect of a herb on the control of blood glucose and insulin-resistance in patients with advanced type 2 diabetes (a double-blind clinical trial) Caspian J Intern Med. 2020;11:12-20.

Hwang HJ, Liu Y, Kim HS, Lee H, Lim Y, Park H. Daily walnut intake improves metabolic syndrome status and increases circulating adiponectin levels: randomized controlled crossover trial. Nutr Res Pract. 2019;13(2):105-14.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA. 2014;311(8);507-20.

Petrović-Oggiano G, Debeljak-Martačić J, Ranković S. The Effect of Walnut Consumption on n-3 Fatty Acid Profile of Healthy People Living in a Non-Mediterranean West Balkan Country, a Small Scale Randomized Study. Nutrients. 2020;12(1):192.

Freisling H, Noh H, Slimani N, Chajes V, May AM, Peeters PH, et al. Nut intake and 5-years changes in body weight and obesity risk in adults. Results from the epic-panacea study. Eur J Nutr. 2018;57(7):2399-408.

Ndanuko RN, Tapsell LC, Charlton KE, Batterham MJ. Effect of individualized dietary advice for weight loss supplemented with walnuts on blood pressure. The Health Track Study. Eur J Clin Nutr. 2018;72(6):894-903.

Wu L, Piotrowski K, Rau T, Waldmann E, Broedl UC, Demmelmair H, Koletzko B, et al. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein b in healthy Caucasian subjects: A randomized controlled cross-over clinical trial. Metabolism. 2014;63(3):382-91.

Bhardwaj R, Dod H, Sandhu MS, Bedi R, Dod S, Konat G, et al. Acute effects of diets rich in almonds and walnuts on endothelial function. Indian Heart J. 2018;70(4):497-501.

Wang S, Zheng L, Zhao T, Zhang Q, Liu Y, Sun B, et al. Inhibitory Effects of Walnut (Juglans regia) Peptides on Neuroinflammation and Oxidative Stress in Lipopolysaccharide-Induced Cognitive Impairment Mice. J Agric Food Chem. 2020;68(8):2381-92.

Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, Bare M, Kennedy M. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care. 2004;27(12):2777-83.

Mirzababaei A, Daneshvar M, Abaj F. The Effect of Walnut (Juglans regia) Leaf Extract on Glycemic Control and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Clin Nutr Res. 2022;11(2):120-32.

Kim KB, Kim K, Kim C, Kang SJ, Kim HJ, Yoon S, Shin YA. Effects of exercise on the body composition and lipid profile of individuals with obesity: A systematic review and meta-analysis. J Obes Metab Syndr. 2019;28(4):278.

Liu JF, Liu YH, Chen CM, Chang WH, CYO. The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus. A randomized crossover controlled feeding trial. Eur J Nutri. 2013;52(3):927-35.

Sweazea KL, Johnston CS, Ricklefs KD, Petersen KN. Almond supplementation in the absence of dietary advice significantly reduces C-creative protein in subjects with type 2 diabetes. J Funct Foods. 2014;10:252-9.

Borkowski K, Yim SJ, Holt RR, Hackman RM, Keen CL, Newman JW, et al. Walnuts Change Lipoprotein Composition Suppressing TNFα-Stimulated Cytokine Production by Diabetic Adipocyte. J Nutr Biochem. 2019;68:51-8.

Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007;165:164-74.

Tan B, Wang Y, Zhang X, Sun X. Recent Studies on Protective Effects of Walnuts against Neuroinflammation. Nutrients. 2022;14(20):4360.

Bitok E, Rajaram S, Jaceldo-Siegl K, Oda K, Sala-Vila A, Serra-Mir M, et al. Effects of long-term walnut supplementation on body weight in free-living elderly: Results of a randomized controlled trial. Nutrients. 2018;10(9):1317.

Rusu ME, Gheldiu AM, Mocan A, Moldovan C, Popa DS, Tomuta I, Vlase L. Process optimization for improved phenolic compounds recovery from walnut (Juglans regia L.) septum: Phytochemical profile and biological activities. Molecules. 2018;23(11):2814.

Ma Y, Njike V, Millet J, Dutta S, Doughty Katz D. Effects of walnut consumption on Endothelia Function in type 2 diabetic. Diabetes care, 2010;33(2):277-32.

Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, et al. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med. 2011;15(6):1339-54.

Haddad EH, Gaban-Chong N, Oda K, Sabaté J. Effect of a walnut meal on postprandial oxidative stress and antioxidants in healthy individuals. Nutr J. 2014;13:4.

Byerley LO, Chang HM, Lorenzen B, Guidry J, Hardman WE. Impact of dietary walnuts, a nutraceutical option, on circulating markers of metabolic dysregulation in a rodent cachectic tumor model. Biomed Pharmacother. 2022;155:113728.

McKay DL, Chen CY, Yeum KJ, Matthan NR, Lichtenstein AH, Blumberg JB. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J. 2010;12;9:21.

Downloads

Published

2024-06-25

How to Cite

Ofor, C. C., Ohanme, E. O., Nwakelu, B. N., Ofornakara, U., Aja, D. O., Shu, E. N., & Ghasi, S. I. (2024). Pharmacological effect of walnuts consumption on metabolic syndrome: a current view. International Journal of Basic & Clinical Pharmacology, 13(4), 536–542. https://doi.org/10.18203/2319-2003.ijbcp20241656

Issue

Section

Review Articles